The Case for Brachytherapy: Why It Deserves a Renaissance
The recent global events related to the coronavirus disease of 2019 pandemic have significantly changed the medical landscape and led to a shift in oncologic treatment perspectives. There is a renewed focus on preserving treatment outcomes while maintaining medical accessibility and decreasing medic...
Main Authors: | Vonetta M. Williams, MD, Jenna M. Kahn, MD, Nikhil G. Thaker, MD, Sushil Beriwal, MD, Paul L. Nguyen, MD, Douglas Arthur, MD, Daniel Petereit, MD, Brandon A. Dyer, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109420303080 |
Similar Items
-
An Unusual Etiology of Severe Right Heart Failure Deserving of Wider Recognition
by: Woosun Kang, MD, MPH, et al.
Published: (2024-03-01) -
Americans Deserve to Get a Better Value From CMMI
by: Louis J. Wilson MD, FACG
Published: (2022-12-01) -
Embolization of prostatic brachytherapy seeds to pulmonary arteries: a case study
by: Alexander D. Calvert, BS, et al.
Published: (2017-03-01) -
Variations in Resources Among Radiation Oncology Residency Programs in the United States
by: Toms Vengaloor Thomas, MD, et al.
Published: (2021-01-01) -
Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01)